- Potential benefitExpands research into Down syndrome and co-occurring conditions, potentially improving targeted treatments.
- Potential benefitIncreased clinical trials inclusive of Down syndrome participants could generate therapies and real-world evidence.
- Potential benefitEstablishing a large cohort and data infrastructure may accelerate discovery and biomarker validation.
DeOndra Dixon INCLUDE Project Act of 2025
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
This bill adds a new section to the Public Health Service Act authorizing the NIH Director to establish the INCLUDE Project, a program of research, training, and investigation related to Down syndrome. It directs NIH to fund basic science, assemble large study populations, expand inclusive clinical trials, study biological mechanisms and biomarkers, investigate co-occurring conditions, improve quality of life, coordinate NIH activities to avoid duplication, provide technical assistance, and submit biennial reports to Congress cataloging supported research and real-world evidence.
Progressives emphasize disability-led engagement and social supports.
Relative to its intended legislative type, this bill clearly creates a statutory mandate for the NIH to carry out a coordinated Down syndrome research program (the INCLUDE Project), defining areas of focus and requiring interagency coordination and biennial congressional reporting.
This bill adds a new section to the Public Health Service Act authorizing the NIH Director to establish the INCLUDE Project, a program of research, training, and investigation related to Down syndrome.
It directs NIH to fund basic science, assemble large study populations, expand inclusive clinical trials, study biological mechanisms and biomarkers, investigate co-occurring conditions, improve quality of life, coordinate NIH activities to avoid duplication, provide technical assistance, and submit biennial reports to Congress cataloging supported research and real-world evidence.
Content is narrowly focused, nonideological, and oversight-oriented; passage hinges mainly on appropriations inclusion and committee prioritization.
Relative to its intended legislative type, this bill clearly creates a statutory mandate for the NIH to carry out a coordinated Down syndrome research program (the INCLUDE Project), defining areas of focus and requiring interagency coordination and biennial congressional reporting. It places responsibility at the NIH Director level and integrates the new program into the Public Health Service Act.
Progressives emphasize disability-led engagement and social supports.
Who stands to gain, and who may push back.
These are examples from the analysis, not a ranked list of the most-affected groups.
- Federal agenciesRequires additional federal spending and likely new appropriations to implement the program.
- Potential burdenAssembling large study populations raises participant privacy and data-security concerns.
- Potential burdenIncreased coordination and reporting may add administrative burden for NIH and grantees.
Why the argument around this bill splits.
Progressives emphasize disability-led engagement and social supports.
Likely broadly supportive because the bill funds inclusive research and aims to improve quality of life for people with Down syndrome.
Would press for disability-community leadership, equitable access to resulting therapies, and safeguards against research that could be used for discriminatory prenatal practices.
Wants funding for social supports as well as biomedical research; some ethical concerns are speculative given bill text.
Generally favorable as targeted biomedical research and coordinated NIH activity are pragmatic goals.
Wants clarity on funding, measurable goals, and oversight to prevent duplication and uncontrolled spending.
Views biennial reporting positively for accountability.
Cautiously receptive to research improving health outcomes for a clearly defined population, but concerned about new federal programs and spending.
Will emphasize limiting federal expansion, preventing regulatory burdens, and favoring private-sector or state roles where appropriate.
Skepticism about open-ended NIH authority and unspecified funding.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Content is narrowly focused, nonideological, and oversight-oriented; passage hinges mainly on appropriations inclusion and committee prioritization.
- No authorization of appropriations or cost estimate in text
- Potential overlap with existing NIH programs and portfolios
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
Progressives emphasize disability-led engagement and social supports.
Content is narrowly focused, nonideological, and oversight-oriented; passage hinges mainly on appropriations inclusion and committee priori…
Relative to its intended legislative type, this bill clearly creates a statutory mandate for the NIH to carry out a coordinated Down syndrome research program (the INCLUDE Project), defining areas of focus and requiring…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.